However, favorable results could be achieved in patients with RA who did not respond to a TNF inhibitor by dual blockage of IL-17A and IL-17F, which indicated that blockage of IL-17 could be a promising option for some patients with RA [41]. The gene discussed is TNF; the disease is rheumatoid arthritis.